K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma

Cancer

Volumn 86, Issue 8, 1999, Pages 1441-1448

  Watanabe, Hiroyuki ^a   Ha, Aiguli ^a   Hu, Yu Xin ^a   Ohtsubo, Koushiro ^a   Yamaguchi, Yasushi ^a   Motoo, Yoshiharu ^a   Okai, Takashi ^a   Toya, Daishu ^b   Tanaka, Nobuyoshi ^b   Sawabu, Norio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

Author keywords

Bile; Biliary tract carcinoma; Duodenal aspirate; K ras mutations at codon 12; Mutant allele specific amplification; Pancreatic carcinoma; Pancreatic juice

Indexed keywords

SECRETIN;

ADULT; AGED; ALLELE; ARTICLE; BILE DUCT CARCINOMA; CANCER SCREENING; DUODENUM SECRETION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PANCREAS BIOPSY; PANCREAS CARCINOMA; PANCREAS JUICE; PANCREAS SECRETION; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BILIARY TRACT NEOPLASMS; BIOPSY, NEEDLE; DNA PRIMERS; DNA, NEOPLASM; DUODENUM; FEMALE; GENES, RAS; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; SECRETIN; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0033569824     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1441::AID-CNCR9>3.0.CO;2-I     Document Type: Article

References (41)

1. Nakaizumi A, Tatsuta M, Uehara H, Yamamoto R, Takenaka A, Kishigami Y, et al. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. Cancer 1992;70:2610-4.
2. Kameya S, Kuno N, Kasugai T. The diagnosis of pancreatic cancer by pancreatic juice cytology. Acta Cytol 1981;25:354-60.
3. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
4. Smit VTHBM, Boot AJM, Fleuren GJ, Cornelisse CJ, Bos JL. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 1988;16:7773-82.
5. Grünewald K, Lyons J, Frölich A, Feichtinger H, Weger RA, Schwab G, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989;43:1037-41.
6. Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S. Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 1989;80:622-6.
7. Nagata Y, Abe M, Motoshima K, Nakayama E, Shiku H. Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese. Jpn J Cancer Res 1990;81:135-40.
8. Tada M, Omata M, Ohto M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991;100:233-8.
9. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994;107:1147-53.
10. Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, et al. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut 1996;38:426-9.
11. Watanabe H, Sawabu N, Ohta H, Satomura Y, Yamakawa O, Motoo Y, et al. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res 1993;84:961-5.
12. Watanabe H, Sawabu N, Songür Y, Yamaguchi Y, Yamakawa O, Satomura Y, et al. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas 1996;12:18-24.
13. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
14. Miki H, Matsumoto S, Harada H, Mori S, Haba R, Ochi K, et al. Detection of c-Ki-ras point mutation from pancreatic juice. Int J Pancreatol 1993;14:145-8.
15. Kondo H, Sugano K, Fukayama N, Kyogoku A, Nose H, Shimada K, et al. Detection of point mutation in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994;73:1589-94.
16. Berthélemy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL, Pradayrol L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995;123:188-91.
17. Takeda S, Ichii S, Nakamura Y. Detection of K-ras mutation in sputum by mutant allele specific amplification (MASA). Hum Mutat 1993;2:112-7.
18. Watanabe H, Miyagi C, Yamaguchi Y, Satomura Y, Ohta H, Motoo Y, et al. Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutations. Jpn J Cancer Res 1996;87:466-74.
19. Imai M, Hoshi T, Ogawa K. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 1994;73:2727-33.
20. Hermanek P, Sobin LH, editors. TNM classification of malignant tumours. 4th edition. New York: Springer-Verlag, 1987.
21. Clinical, surgical, and comprehensive findings. In: Japan Pancreas Society, editor. Classification of pancreatic carcinoma [1st English edition]. Tokyo: Kanehara Co., 1996:2-14.
22. Homma T, Harada H, Koizumi M. Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society. Pancreas 1997;15:14-5.
23. Bowtell DD. Rapid isolation of eukaryotic DNA. Anal Biochem 1987;162:463-5.
24. Jeanpiérrè M. A rapid method for the purification of DNA from blood. Nucleic Acids Res 1987;15:9611.
25. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
26. Klöppel G. Gene changes and pancreatic carcinoma. The significance of K-ras. Dig Surg 1994;11:164-9.
27. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
28. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-73.
29. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996;110:227-31.
30. Furuya N, Kawa S, Akamatsu T, Furihata K. Long-term follow up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 1997;113:593-8.
31. Watanabe H, Yamaguchi Y, Ha A, Hu Y-X, Motoo Y, Okai T, et al. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay. Pancreas 1998;17:341-7.
32. Iguchi H, Sugano K, Fukayama N, Ohkura H, Sadamoto K, Ohkoshi K, et al. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology 1996;110:221-6.
33. Wilentz RE, Chung CH, Sturm PDJ, Musler A, Sohn TA, Offerhaus GJA, et al. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 1998;82:96-103.
34. Tada M, Yokosuka O, Omata M, Ohio M, Isono K. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990;66:930-5.
35. Motojima K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg 1991;214:657-62.
36. Stork P, Loda M, Bosari S, Wiley B, Poppenhusen K, Wolf H. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Oncogene 1991;6:857-62.
37. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
38. Ajiki T, Onoyama H, Yamamoto M, Fujimori T, Maeda S, Saitoh Y. Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures. Int J Pancreatol 1995;18:215-20.
39. Ito R, Tamura K, Ashida H, Nishikawa M, Nishioka A, Yamamoto Y, et al. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures. Int J Oncol 1998;12:1019-23.
40. Lee JG, Leung JW, Cotton PB, Layfield LJ, Mannon PJ. Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1995;42:317-20.
41. Tanno S, Obara T, Fuji T, Mizukami Y, Shudo R, Nishino N, et al. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer 1998; 83:267-75.